Patricia A. Martin - 19 Dec 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Patricia A. Martin
Issuer symbol
ANTX
Transactions as of
19 Dec 2024
Net transactions value
$0
Form type
4
Filing time
23 Dec 2024, 18:42:57 UTC
Previous filing
04 Oct 2024
Next filing
11 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +3,166 $0.000000 3,166 19 Dec 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.